Abiopharma

Director Flatt Stephen Fowler 🟡 adjusted position in 47.3K shares (4 derivative) of NATIONAL HEALTHCARE CORP (NHC) at $157.13 ($5.7M) Transaction Date: Mar 12, 2026 | Filing ID: 008414

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026

Natural Gas Services Group, Inc. Reports Fourth Quarter and Full Year 2025 Financial and Operating Results; Provides 2026 Guidance

F&G Annuities & Life Announces New Three-Year $100 Million Share Repurchase Program

Regal Rexnord Provides Update on CEO Succession Process

Greystone Housing Impact Investors Reports Fourth Quarter 2025 Financial Results

Smiley Joshua L 🟡 adjusted position in 135.8K shares (3 derivative) of Zai Lab Ltd (ZLAB) at $19.27 ($2.0M) Transaction Date: Mar 04, 2026 | Filing ID: 001286

KIDD BRIAN F 🟡 adjusted position in 35.6K shares (4 derivative) of NATIONAL HEALTHCARE CORP (NHC) at $157.13 ($4.2M) Transaction Date: Mar 12, 2026 | Filing ID: 008408

Edmondson Frazor Titus III 🟡 adjusted position in 108.9K shares (3 derivative) of Zai Lab Ltd (ZLAB) at $19.27 ($1.6M) Transaction Date: Mar 04, 2026 | Filing ID: 001285

📋 Morais Mark A. (Officer) plans to sell 2K shares of Fortrea Holdings Inc. (at $9.22 each, total $17K) Filed: Mar 16, 2026 | ID: 002380

Chen Yajing 🟡 adjusted position in 108.5K shares (3 derivative) of Zai Lab Ltd (ZLAB) at $19.27 ($1.6M) Transaction Date: Mar 04, 2026 | Filing ID: 001284

Director Khattar Jack A. 🟡 adjusted position in 35.0K shares of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $51.75 ($1.8M) Transaction Date: Mar 13, 2026 | Filing ID: 000008

Juvenal Tobin W 🔴 sold 20.9K shares of CASTLE BIOSCIENCES INC (CSTL) at $25.24 Transaction Date: Mar 12, 2026 | Filing ID: 018156

Burkhalter Danielle 🔴 sold 3.5K shares of Surgery Partners, Inc. (SGRY) at $12.83 Transaction Date: Mar 13, 2026 | Filing ID: 000034